This vaccine protects against pneumococcal infections, which are especially dangerous in children younger than 5 years old. The Centers for Disease Control and Prevention (CDC) recommends that all ...

Meningitis can be a frightening diagnosis. Our expert guide breaks down the different types—bacterial, viral, and fungal—and ...

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.

THE association of salmonella osteomyelitis with sickle-cell anemia is well known,1 but that of pneumococcal meningitis with sickle-cell anemia has not been reported. In a recent survey of 305 pati ...

Since pneumococcal meningitis is not always a primary disease, particularly in adults, it was interesting to determine the apparent source of the infection in the present series . A primary ...

CHESTERTON -- Roxann and Dean Campbell did everything they could, did all the right things.

Nonetheless, in 2019, the global incidence of bacterial meningitis was still 2.5 million, resulting in 236,000 deaths and long-term complications such as deafness, seizures, or worse in roughly ...

Now, pneumococcal and meningococcal meningitis are still number one, but the epidemiology has shifted from kids to adults. In the 1980s, the median age of bacterial meningitis were infants with H ...

Pneumococcal meningitis most often affects babies and young children under 18 months of age. A type of bacteria called Streptococcus pneumonia causes this form of the condition.

But what the researchers found was that during pneumococcal meningitis, the AQP4-water channel lost its natural place and connection with the blood-brain barrier (BBB) vessel wall.

This region is at high-risk of epidemics of both meningococcal and pneumococcal meningitis. The NmCV-5 vaccine was developed by the Serum Institute of India and PATH, the global division of the ...

The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically ...